Health News
1 in 4 Women Skips Breast Cancer Therapy
The majority of breast cancers are fed by the hormones estrogen and progesterone. That’s why women with hormone-sensitive breast cancer are prescribed medicines to block these hormones. But a good portion of women may be skipping the therapy.
Voluntary Type II Recall for Alysena 28
Apotex had initiated a voluntary Type II recall to the retail and pharmacy level for Alysena™ 28 (lot LF01899A), on behalf of the fabricator, Laboratorios Leon Farma SA, due to the potential for a packaged unit to contain two rows of placebo instead of one row (14 tablets instead of 7 tablets) and two rows of active contraceptive tablets (14 tablets instead of 21 tablets) in the blister pack.
Extra Pounds Weigh Heavy on Female Hearts
Obesity is bad for the heart. While some research has found that a little extra fat may help you live longer, a new study finds that even a slight rise in BMI can tip the scales against you.
Smoking is Bad for Bone Health
Osteoporosis is often regarded as a disease of old age. But the path to osteoporosis may start much earlier in life, especially for girls who smoke or show signs of depression.
Palbociclib Receives FDA Breakthrough Therapy Designation
Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the United States Food and Drug Administration (FDA) for the potential treatment of patients with breast cancer.
Looking into Breast Cancer Breakthrough
The FDA has given Pfizer’s breast cancer compound a “Breakthrough Therapy” designation. This will fast-track the medication’s development and review because this compound may offer important new treatments advantages.
When Pregnant Women Live in Risky Places
Most people have the good fortune not to live in a town under regular rocket attacks. However, lessons can be learned from the experiences of pregnant women in such places.
Movement Can Move the Cancer Risk Gauge
We wouldn’t be women without estrogen. The hormone controls our sexual features and our ability to carry children. This hormone also drives the most common forms of breast cancer.
FDA Approves Diclegis
The US Food and Drug Administration today approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and vomiting.
Skipping Chemo to Treat a Breast Cancer
Aggressive breast cancer requires aggressive treatment. The therapy for one menacing type of breast cancer – HER2-positive – almost always involves chemotherapy. Maybe not for everyone, though.